A report of rarely observed resistance pattern to carbapenems in a clinical isolate of enterobacter cloacae;Prikaz rijetko videnog oblika otpornosti na karbapeneme u vrste enterobacter cloacae

Lijecnicki Vjesnik

Volumn 135, Issue 11-12, 2013, Pages 316-321

  Bejuk, Danijela ^a   Novkoski, Mladen ^c   Juranko, Vlado ^c   Prajdić Predrijevac, Davorka ^c   Todorić, Nives ^c   Mikačić, Ivana ^b   Gužvinec, Marija ^d   Andrašević, Arjana Tambić ^d  

^a KB Sveti Duh ^*  (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Fakulteta Sveu ili ta J J Strossmayera u Osijeku   (Croatia)

^d Croatia   (Croatia)

Author keywords

Beta lactam resistance; Beta lactamases genetics, metabolism; Carbapenems pharmacology, therapeutic use; Enterobacter cloacae isolation and purification, enzymology, drug efiffects; Enterobacteriaceae infections microbiology, drug therapy

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; MEROPENEM; THIENAMYCIN DERIVATIVE;

AGED; ANTIBIOTIC RESISTANCE; CASE REPORT; CROATIA; DRUG EFFECTS; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; HUMAN; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY;

AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CROATIA; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; HUMANS; MALE; THIENAMYCINS;

EID: 84893028964     PISSN: 00243477     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Sanders WE, Sanders CC. Enterobacter spp. Pathogens poised to flourish at the turn of the century. Clin Microbiol Rev 1997;10(2):220-41.
2. Liu YC, Chen TL, Chen HS i sur. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteraemia. J Microbiol Immunol Infect 2006;39:67-72.
3. Falcone M, Mezzatesta ML, Perilli M i sur. Infections with VIM-1 metallo-beta-lactamase-producing Enterobacter cloacae and their correlation with clinical outcome. J Clin Microbiol 2009;47(11):3514-9.
4. Miriagou V, Cornaglia G, Edelstein M i sur. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 2010;16:112-22.
5. Giske CG, Gezelius L, Samuelsen O i sur. A sensitive and specific phenotypic assay for detection of metallo-beta-lactamase and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infect 2011;17(4):552-6.
6. Birgy Y, Bidet P, Genel C i sur. Phenotypic screening of carbapenemases and associated beta-lactamases in carbapenem-resistant Enterobacteriaceae. J Clin Microbiol 2012;50(4):1295-302.
7. Nordmann P, Gniadkowski M, Giske CG i sur. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 2012;18:432-8.
8. th Informational Supplement. CLSI document M100-S19. Wayne PA: Clinical and Laboratory Standards Institute; 2009.
9. European Committee on Antimicrobial Susceptibility Testing (EUCAST). Website with MIC-distributions. (http://mic.eucast.org/dostupno od travnja 2010. godine).
10. Anderson KF, Lonsway DR, Rasheed JK i sur. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol 2007;45:2723-25.
11. Tzouvelekis LS, Tzelepi E, Mentis AF i sur. Imipenem resistance in Enterobacter aerogenes is associated with derepression of chromosomal cephalosporinases and impared permeability. FEMS Microbiol Lett 1992;74(2-3):195-9.
12. Thompson KS, Sanders CC, Chmel H. Imipenem resistance in Enterobacter. Eur J Clin Microbiol Infect Dis 1993;12(8):610-13.
13. Mainardi JL, Mugnier P, Coutrot A i sur. Carbapenem resistance in a clinical isolate of Citrobacter freundii. Antimicrob Agents Chemother 1997;41(11):2352-4.
14. Bradford PA, Urban C, Mariano N i sur. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT, a plasmid mediated AmpC beta-lactamase and the loss of an outer membrane protein. Antimicrob Agents Chemother 1997;41(3):563-9.
15. Yigit H, Anderson GJ, Biddle JW i sur. Carbapenem resistance in a clinical isolate of Enterobacter aerogenes is associated with decreased expression of OmpF and OmpC porin analogs. Antimicrob Agents Chemother 2002;46:3817-22.
16. Gayet S, Cholet R, Molle G i sur. Modification of outer membrane protein profile and evidence suggesting an active drug pump in Enterobacter aerogenes clinical strains. Antimicrob Agents Chemother 2003;47(5):1555-9.
17. Nordmann P, Mariotte S, Naas T i sur. Biochemical properties of a carbapenem-hydrolyzing beta-lactamase from Enterobacter cloacae and cloning of a gene into Escherichia coli. Antimicrob Agents Chemother 1993;37(5):939-46.
18. Lauretti L, Riccio ML, Mazzariol A i sur. Cloning and characterization of blaVIM, a new integron-borne metallo-beta-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 1999;43(7):1584-90.
19. Cornaglia G, Riccio ML, Mazzariol A i sur. Appearance of IMP-1 metallo-beta-lactamase in Europe. Lancet 1999;353:899-900.
20. Sardelić S, Pallecchi L, Punda-Polić V i sur. Carbapenem resistant Pseudomonas aeruginosa-cmying VIM-2 metallo-beta-lactamase determinants, Croatia. Emerg Infect Dis 2003;9(8):1022-3.
21. Miriagou V, Tzelepi E, Gianneli D i sur. Escherichia coli with a self transferable, multiresistant plasmid coding for metallo-beta-lactamase VIM-1. Antimicrob Agents Chemother 2003;47:395-7.
22. Galani I, Souli M, Chryssouli Z i sur. Characterization of a new integron containing bla (VIM-l) and aac (6)-IIc in an Enterobacter cloacae clinical isolate from Greece. J Antimicrob Chemother 2005;55:634-8.
23. Vatopoulos A. High rates of metallo-beta-lactamase-producing Klebsiella pneumoniae in Greece - a review of a current evidence. Euro Surveill 2008;13(4) pii = 8023.
24. Yong D, Toleman MA, Giske CG i sur. Characterization of a new metallo-beta-lactamase gene bla (NDM-l), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 2009;53:5046-54.
25. Struelens M. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill 2010;15(46):pii=19716.
26. Nordmann P, Poirel L, Toleman MA i sur. Does broad-spectrum betalactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J Antimicrob Chemother 2011;66:689-92.
27. Mazzariol A, Bošnjak Z, Ballarin P i sur. NDM-1-producing Klebsiella pneumoniae, Croatia. Emerg Infect Dis 2012;18(3):532-4.
28. Yigit H, Queenan AM, Anderson GJ i sur. Novel carbapenem-hydrolizing beta-lactamase, KPC-1 from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001;45:1151-61.
29. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011;17(10):1791-8.
30. Naas T, Nordmann P, Vedel G i sur. Plasmid-mediated carbapenem- hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate in France. Antimicrob Agents Chemother 2005:49: 4423-4.
31. Leavitt A, Navon-Venezia S, Chmelnitsky A i sur. Emergence of KPC2 and KPC3 in carbapenem resistant Klebsiella pneumoniae in an Israel hospital. Antimicrob Agents Chemother 2007;51:3026-9.
32. Giakkoupi P, Maltezou H, Polemis M i sur. KPC-2 producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill 2009;14(21):pii=19218.
33. Zagorianou A, Sianou E, Iosifldis E i sur. Microbiological and molecular characteristics of carbapenemase-producing Klebsiella pneumoniae endemic in a tertiary Greek hospital during 2004-2010. Euro Surveill 2012;17(7):pii=20088.
34. Bedenic B, Mazzariol A, Plecko V i sur. First report of KPC producing Klebsiella pneumoniae in Croatia. J Chemother 2012;24(4):237-9.
35. Bratu S, Brooks S, Burney S i sur. Detection and spread of E. coli possessing the plasmid borne carbapenemase KPC-2 in Brooklyn New York. Clin Infect Dis 2007;44:972-5.
36. Marchaim D, Navon-Venezia S, Schwaber MJ, Carmeli Y. Isolation of imipenem resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology and outcome. Antimicrob Agents Chemother 2008;52(49):1413-8.
37. Gomez-Gil MR, Pano-Pardo JR. Romero-Gomez MP i sur. Detecting of KPC-2-producing Citrobacter freundii isolates in Spain. J Antimicrob Chemother 2010;65(12):2695-7.
38. Canton R, Akova M, Carmeli Y i sur. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 2012;18:413-31.
39. Tsakris A, Poulou A, Thelemi-Digataki K i sur. Use of boronic acid disk tests to detect extended-spectrum beta-lactamases in clinical isolates of KPC carbapenemase-possessing Enterobacteriaceae. J Clin Microbiol 2009;47(11):3420-6.
40. Rasmussen JW, Hoiby N. Class A carbapenemases. J Antimicrob Chemother 2007;60(3):470-82.
41. Pournaras S, Poulou A, Tsakris A i sur. Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds. J Antimicrob Chemother 2010;65(7) 1319-21.
42. Tsakris A, Themeli-Digalaki K, Poulou A i sur. Comparative evaluation of combined-disk test using different boronic acid compounds for detection of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae clinical isolates. J Clin Microbiol 2011;49:2804-9.
43. European Committee on Antimicrobial Susceptibility Testing (EU-CAST). Website with MIC-distributions. (http://mic.eucast.org/dostupno od prosinca 2012. godine).
44. Hirsch EB, Tarn VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs). An emerging cause of multidrug-resistant infection. J Antimicrob Chemother 2010;65:1119-25.
45. Arnold RS, Thorn KA, Sharma S i sur. Emergence of Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria. South Med J 2011;104(1) 40-5.
46. Carmeli Y, Akova M, Cornaglia G i sur. Controlling the spread of carbapenemase-producing gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010;16:102-11.
47. Anthony KB, Fishman NO, Linkin DR i sur. Clinical and microbiological outcomes of serious infections with multidrug-resistant gramnegative organisms treated with tigecycline. Clin Infect Dis 2008;46:567-70.
48. Souli M, Kontopidou F, Papadomichelakis E i sur. Clinical experience of serious infections caused by Enterobacteriacae producing VIM-1 metallo-beta-lactamase in a Greek university hospital. Clin Infect Dis 2008;46:847-54.
49. Daikos GL, Petrikkos P, Psichogiou M i sur. Prospective observational study of the impact of VIM-1 metallo-beta-lactamase on the outcome of patients with Klebsiella pneumoniae bloodstream infections. Antimicrob Agents Chemother 2009;53:1868-73.
50. Daikos GL, Markogiannakis A. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? Clin microbial Infect 2011;17:1135-41.
51. Keel RA, Sutherland CA, Crandon JL i sur. Stability of doripenem, imipenem and meropenem at elevated room temperatures. Int J Antimicrob Ag 2011;37:174-85.
52. Poudyal A, Howden BP, Bell JM. In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae. J Antimicrob Chemother 2008;62:1311-18.
53. Bogdanovich T, Adams Haduch JM, Tian GB i sur. Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone. ST258. Clin Infect Dis; 2011;53(4):373-6.
54. Falagas ME, Rafailidis PI. Colistin in ventilator associated pneumonia. Clin Infect Dis 2012;54(5):681-3.
55. Humphries RM, Kelesidis T, Dien Bard J i sur. Successful treatment of pan resistant Klebsiella pneumoniae pneumonia and bacteraemia with a combination of high-dose tigecycline and colistin. J Med Microbiol 2010;59:1383-6.
56. Spanu T, De Angelis G, Cipriani M i sur. In vivo emergence of tigecycline resistance in multidrug-resistant Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 2012;56(8):4516-8.
57. Naas T, Cattoen C, Bernusset S i sur. First identification of blaIMI-1 in an Enterobacter cloacae clinical isolate from France. Antimicrob Agents Chemother 2012;56(3):1664-5.